PRIMECAP Management Co.
Institutional investor · Portfolio as of Q1 2024
Top Holdings335 positions
 Eli Lilly and Company | 21.3M | $16.5B | 12.3% | $104.89 | +629.19% | 22 qtrssince 2018-Q4 | Decreased 0 |
 Micron Technology, Inc. | 37.6M | $4.4B | 3.3% | $31.21 | +274.95% | 22 qtrssince 2018-Q4 | Increased 59 |
 Microsoft Corporation | 10.2M | $4.3B | 3.2% | $94.43 | +337.01% | 22 qtrssince 2018-Q4 | Decreased 0 |
 Amgen Inc. | 14.6M | $4.2B | 3.1% | $154.34 | +71.03% | 22 qtrssince 2018-Q4 | Increased 58 |
 KLA Corporation | 5.8M | $4B | 3.0% | $8.13 | +743.63% | 22 qtrssince 2018-Q4 | Decreased 0 |
 FedEx Corporation | 12.9M | $3.7B | 2.8% | $117.29 | +89.28% | 22 qtrssince 2018-Q4 | Decreased 0 |
 Biogen Inc. | 16.2M | $3.5B | 2.6% | $298.22 | -27.69% | 22 qtrssince 2018-Q4 | Decreased 0 |
 Intel Corporation | 76.1M | $3.4B | 2.5% | $38.62 | +13.18% | 22 qtrssince 2018-Q4 | Increased 55 |
 Adobe Inc. | 5.9M | $3B | 2.2% | $226.24 | +123.04% | 22 qtrssince 2018-Q4 | Decreased 0 |
 AstraZeneca PLC | 42.9M | $2.9B | 2.2% | $64.10 | +103.59% | 22 qtrssince 2018-Q4 | Decreased 0 |
 Alphabet Inc. | 19.1M | $2.9B | 2.2% | $52.04 | +187.30% | 22 qtrssince 2018-Q4 | Decreased 0 |
 Texas Instruments Incorporated | 15.5M | $2.7B | 2.0% | $75.82 | +113.45% | 22 qtrssince 2018-Q4 | Decreased 0 |
 Boston Scientific Corporation | 37.9M | $2.6B | 1.9% | $36.09 | +89.76% | 22 qtrssince 2018-Q4 | Increased 50 |
 Wells Fargo & Company | 42.4M | $2.5B | 1.8% | $36.98 | +48.07% | 22 qtrssince 2018-Q4 | Decreased 0 |
 NVIDIA Corporation | 2.3M | $2.1B | 1.6% | $3.30 | +2628.62% | 22 qtrssince 2018-Q4 | Decreased 0 |
 Alphabet Inc. | 12.7M | $1.9B | 1.4% | $51.29 | +194.05% | 22 qtrssince 2018-Q4 | Decreased 0 |
 Sony Group Corporation | 21.7M | $1.9B | 1.4% | $9.26 | +83.99% | 22 qtrssince 2018-Q4 | Decreased 0 |
 Oracle Corporation | 13.1M | $1.6B | 1.2% | $52.09 | +133.67% | 22 qtrssince 2018-Q4 | Decreased 0 |
 BioMarin Pharmaceutical Inc. | 18.7M | $1.6B | 1.2% | $84.74 | +3.06% | 22 qtrssince 2018-Q4 | Increased 51 |
 Thermo Fisher Scientific Inc | 2.8M | $1.6B | 1.2% | $222.42 | +159.14% | 22 qtrssince 2018-Q4 | Decreased 0 |
| Quarter | Reported value in US dollars | Reported value change |
|---|---|---|
| 2022-Q4 | $109,229,662,042 | 5.6961877513% |
| 2023-Q1 | $114,683,087,222 | 4.99262295429% |
| 2023-Q2 | $119,679,111,009 | 4.35637364499% |
| 2023-Q3 | $118,467,586,724 | -1.01231056513% |
| 2023-Q4 | $126,313,639,154 | 6.62295286582% |
| 2024-Q1 | $134,077,213,045 | 6.14626729385% |
PRIMECAP Management Co. manages $134.1B across 335 positions as of Q1 2024. Top holdings: LLY (12.3%), MU (3.3%), MSFT (3.2%). Fund DNA: Steady Compounder. HoldingsIntel Score: 3/5.0.
Active quarter - 6 new positions, 5 exits, 107 increased. Top move: MU (INCREASED, conviction 59). Portfolio: $134.1B across 335 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Famous Investors' Portfolios
What the most-followed managers hold, and what they bought and sold each quarter.
- Warren Buffett (Chairman Emeritus)Berkshire Hathaway
- Leopold AschenbrennerSituational Awareness
- Michael BurryScion Asset Management
- Cathie WoodARK Invest
- Bill AckmanPershing Square
- Stanley DruckenmillerDuquesne Family Office
- David TepperAppaloosa
- Ray Dalio (Founder)Bridgewater Associates
- Li LuHimalaya Capital
- Carl IcahnCarl C. Icahn
- Brad GerstnerAltimeter Capital
- Seth KlarmanThe Baupost Group
- Howard Marks (Co‑founder)Oaktree Capital Management
- Ken GriffinCitadel
- Paul Tudor JonesTudor Investment Corp
- George Soros (Founder)Soros Fund Management
- Steve CohenPoint72
- Terry SmithFundsmith
- Ken Fisher (Founder)Fisher Investments
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR